Skip to main content
. 2020 May 21;9(5):1555. doi: 10.3390/jcm9051555

Table 2.

Cut-off levels, sensitivities and specificities of biomarkers for development of RA in patients with UA.

Biomarker Optimal Cut-Off Sensitivity (%) Specificity (%)
IL-15 36.4 pg/mL 77.8 80.9
anti-CCP Abs 62.8 IU/mL 66.7 76.6
RF 20.9 IU/mL 61.1 87.2

Areas under the ROC curves were used to compute sensitivity and specificity of biomarkers and to determine the optimal cut-offs.